Cancer Genetics is a precision and translational medicine company that offers proprietary preclinical test systems through its vivoPharm subsidiary. These test systems are highly valued by the pharmaceutical industry, biotech companies, and academic research centers in the early stages of clinical diagnostics. The company's focus is on driving drug discovery and developing novel therapies. vivoPharm conducts tailored studies guiding drug development from compound libraries to in vitro and in vivo data to support Investigational New Drug filings. The subsidiary operates in AAALAC accredited and GLP compliant audited facilities.